Business
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor
About this update from Abcellera Biologics Inc.
VANCOUVER, British Columbia --(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences: Truist Securities BioPharma Symposium, November 6, 2025 Stifel Healthcare Conference , November 11-13, 2025 Jefferies Global Healthcare Conference , November 18-20, 2025 Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025 Visit AbCellera's Investor Relations website for additional information. About AbCellera Biologics Inc . AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20251007123988/en/ Inquiries Media: Tiffany Chiu ; [email protected] , +1(236)521-6774 Partnering: Murray McCutcheon , Ph.D.; [email protected] , +1(604)559-9005 Investor Relations: Peter Ahn ; [email protected] , +1(778)729-9116 Source: AbCellera Biologics Inc.
View stock analysis, news, and events for Abcellera Biologics Inc.